technologymarketplacecurrent R&Dservicesnewsemail

Home

company info

about us

management
and board of
directors


scientific
advisory
board

 

video

View our
Small Particle
Crystalization Proces:


 

CritiTech, Inc. conducts research and development into the production and application of fine-particle compounds. The company has expanded its operations to include applications in fine particle API production, coatings, and internal product development.

Recent News & Press Releases

June 4, 2009 :: CritiTech Announces New CEO

April 2009 :: SCF/CritiTech Announce NIH/NCI Grant

September 2008 :: Nanotax Collaboration Article

July 31, 2008 :: Phase 1 Trial for Nanotax has
begun at The University of Kansas Cancer Center.


news archive

Clinical Trials

Nanotax
(Ovarian Cancer)

 

 

contact info

CritiTech, Inc.
1321 Wakarusa Dr.
Suite 2102
Lawrence Kansas
66049
USA


ph: 785.841.7120
fax: 785.841.7268


info@crititech.com

downloads

nanotax product
profile (.doc)


production of
fine particles
with ultrasonic
energy (PDF)


nanotax ovarian
cancer mouse
model (PDF)


upcoming and
recent events


 

 

home | technology | marketplace | current R&D | services | email us
about us | management & board of directors | scientific advisory board | news

© 2007 CritiTech, Inc. : All Rights Reserved